is compiled and published solely as an informational service to Duke
researchers, scholars, and staff.
National Institutes of Health - Alliance of Glycobiologists for Detection of Cancer (U01)
The purpose of this Funding Opportunity Announcement (FOA) is to continue support for the program referred to as the “Alliance of Glycobiologists for Detection of Cancer” (http://glycomics.cancer.gov). Through this FOA, the NCI solicits new and competing renewal applications for research projects to elucidate how changes in cellular carbohydrates may promote cancer initiation and progression and use this information to identify glycan-based abnormalities that have the potential to serve as biomarkers for early cancer detection or risk assessment. These changes may be studied at the level of glycoproteins, glycolipids, glycosaminoglycans, and/or their binding proteins. The proposed projects must also address the ability of these biomarker candidates to accurately distinguish individuals with cancer from those without. It is expected that the most promising biomarker candidates will ultimately be tested in clinical validation studies, although such validation studies are not required for the proposed projects. In addition to planning for the individual research projects, the applicants responding to this FOA must plan for the participation in trans-Alliance activities, including collaborative projects with other awardees.
All investigators with appropriate expertise and capabilities, irrespective of any prior association with the Alliance, are encouraged to consider applying to this FOA.
NOTE on Pre-Application Meeting: The NCI will hold a public pre-application meeting for investigators planning to submit applications in response to this FOA. This meeting will be open to the public and will be also available via NIH teleconferencing technologies. For updates and additional details on the pre-application meeting, please go to the Alliance web site at http://glycomics.cancer.gov. Participation in the meeting, although encouraged, is optional and not required for application submission.
RFA-CA-11-009 Expiration Date October 8, 2011
- Letter of Intent Due Date: September 7, 2011
- Application Due Date(s): October 7, 2011 by 5:00 PM local time of applicant organization.
The official announcement and description of this opportunity may
be found on the funding agency's website:
Environmental & Life Sciences; Medical - Basic Science; Medical - Clinical Science.
Application budgets are limited to $350,000 in direct costs for any single year. The maximum period is 5 years.
External Deadline: 10/7/2011
|Note: For Duke researchers, scholars, and staff.
Duke University is served by two pre-award offices. The
Office of Research Support assists Campus Schools and Centers. The
Office of Research Administration supports the School of Medicine and
the School of Nursing in Duke University Medical Center.
|The Office of Research Administration -
For School of Medicine and School of Nursing
|The Office of Research Support -
For Campus Schools and Centers
|The Office of Research Administration must review all Duke University Medical Center applications for the School of Medicine and School of Nursing prior to submission to the sponsor. Business proposals are due at the ORA offices seven (7) business days in advance of the sponsor deadline.
||The Office of Research Support must review all Duke University applications for Campus Schools and Centers prior to submission to the sponsor. Business proposals are due at the ORS offices five (5) business days in advance of sponsor the deadline.
|The Office of Research Administration
Duke University Medical Center
Suite 802, Erwin Square
2200 West Main Street
Durham, NC 27705
|The Office of Research Support
Suite 710 Erwin Square
2200 West. Main Street
Durham, NC 27705
Report outdated summary information to email@example.com
Last updated 8/1/2011